Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021 Appendix I: Difference between revisions

From GxPlex

Jump to: navigation, search
← Older edit
gxplex>GxPlexBot
Import from GxPlex Excel
m 1 revision imported
 
(6 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{#set:
{{ReferenceData
|HasDocument=Document:EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021
|has_document=Document:EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021
|RefScope=G
|module=4
|RefDocPart=Appendix I
|unit=4.1.4
|RefLanguage=EN
|scope=G
|RefTagsEN=
|doc_part=Appendix I
|RefTagsOriginal=
|language=EN
|RefTagsFR=
|entry_by=Florian Adragna
|contributors=
|tags=TAG-00049-Ser-Ver ++ TAG-00327-Exa-spi
|tags_display=[[Glossary:TAG-00049-Ser-Ver|Serious breach]], [[Glossary:TAG-00327-Exa-spi|Examples]]
|comment=Examples of serious breaches
|content=Appendix I – Examples of serious breaches
}}
}}
{{:Document:EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021}}
{| class="gplx-infobox"
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Scope
| G
|-
! Document part
| Appendix I
|-
! Language
| EN
|-
! Original entry by
| Florian Adragna
|-
! Contributors
|
|-
! Tags (EN)
|
|-
! Tags (original language)
|
|-
! Tags (FR)
|
|-
! Comment
| Examples of serious breaches
|}
== Content ==
Appendix I – Examples of serious breaches

Latest revision as of 13:50, 16 July 2026



Document information
Reference EU EMA/698382/2021

- Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021

Validity area EU
Scope(s) G
Document name EMA/698382/2021

- Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol

Version / Revision 2021
Status Current
Document type Official guideline
Language(s) EN
Description EMA/698382/2021

Quality and Safety of Medicines Department Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 4 — Unit 4.1.4
Scope G
Document part Appendix I
Language EN
Original entry by Florian Adragna
Contributors
Tags Serious breach, Examples

Content

Appendix I – Examples of serious breaches

Retrieved from "https://gxplex.org/index.php?title=Reference:EU_EMA/698382/2021_-_Guideline_for_the_notification_of_serious_breaches_of_Regulation_(EU)_No_536/2014_or_the_clinical_trial_protocol_2021_Appendix_I&oldid=18559"